Follow-up modality | Total performed† | Within 6 mo | Within 12 mo | Within 2 yr | Within 5 yr | Never performed | No data available |
---|---|---|---|---|---|---|---|
Physical examination | 97.8 | 67.0 | 20.9 | 5.5 | 4.4 | 0 | 2.2 |
Serum Tg | 68.1 | 37.4 | 15.4 | 11.0 | 4.4 | 14.3 | 17.6 |
Anti-Tg Ab | 61.5 | 29.7 | 12.1 | 12.1 | 7.7 | 30.8 | 7.7 |
TSH | 86.8 | 67.0 | 13.2 | 4.4 | 2.2 | 3.3 | 9.9 |
T4 | 68.1 | 49.5 | 14.3 | 3.3 | 1.1 | 15.4 | 16.5 |
Cervical ultrasonography | 57.1 | 25.3 | 9.9 | 11.0 | 11.0 | 39.6 | 3.3 |
DxWBS | 35.2 | 7.7 | 4.4 | 11.0 | 12.1 | 56.0 | 8.8 |
PET | 0 | 0 | 0 | 0 | 0 | 82.9 | 12.1 |
CT | 12.1 | 4.4 | 1.1 | 3.3 | 3.3 | 82.4 | 5.5 |
MRI | 2.2 | 0 | 1.1 | 0 | 1.1 | 82.4 | 15.4 |
CT = computed tomography; DxWBS = diagnostic whole body radioiodine scan; MRI = magnetic resonance imaging; PET = positron emission tomography; TSH = thyroid stimulating hormone.
↵* n = 91.
↵† Total performed represents total number and proportion of patients who received at least 1 of the follow-up modality.